Antibiotics in   United States

Overview In June 2024 United States' Antibiotics exports accounted up to $72.7M and imports accounted up to $44.5M, resulting in a positive trade balance of $28.1M. Between June 2023 and June 2024 the exports of United States'   Antibiotics have decreased by $-44.4M (-37.9%) from $117M to $72.7M, while imports decreased by $-4.74M (-9.61%) from $49.3M to $44.5M.

Destinations In June 2024, Antibiotics were exported mostly to Panama ($44.9M), France ($12.8M), Italy ($6.54M), China ($2.28M), and United Kingdom ($1.57M), and were imported mostly from China ($21.7M), Croatia ($8.24M), Italy ($3.3M), Bulgaria ($2.77M), and India ($2.42M).

Growth In June 2024, the decrease in Antibiotics's year-by-year exports was explained primarily by a decrease in exports to France ($-4.97M or -52.4%), China ($-1.73M or -68.7%), and Japan ($-526k or -45%). In June 2024, the decrease in Antibiotics's year-by-year imports was explained primarily by a decrease in imports from Japan ($-6.1M or -99.9%), Switzerland ($-2.58M or -99.2%), and Italy ($-2.04M or -49.1%).